Krensavage Asset Management, LLC Long-Term Concentrated

CIK: 0001609251 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 15, 2023

Total Value ($000): $324 (100.0% shares, 0.0% debt)

Holdings (12)

UTHR UNITED THERAPEUTICS CORP 16.5%
Value ($000) $53 Shares 192,048 Est. Cost $121.76 Unrealized +107.3%
BIIB BIOGEN INC 15.1%
Value ($000) $49 Shares 177,004 Est. Cost $267.94 Unrealized +5.4%
REGN REGENERON PHARMACEUTICALS 13.4%
Value ($000) $43 Shares 60,103 Est. Cost $342.96 Unrealized +114.0%
ALKS ALKERMES PLC 11.3%
Value ($000) $37 Shares 1,401,783 Est. Cost $18.73 Unrealized +27.7%
EXEL EXELIXIS INC 10.6%
Value ($000) $34 Shares 2,138,039 Est. Cost $18.49 Unrealized -11.8%
ENTA ENANTA PHARMACEUTICALS INC 8.5%
Value ($000) $28 Shares 594,818 Est. Cost $45.84 Unrealized -0.5%
EMBC EMBECTA CORP 8.0%
Value ($000) $26 Shares 1,017,657 Est. Cost $25.42 Unrealized +6.5%
CAH CARDINAL HEALTH INC 7.9%
Value ($000) $26 Shares 332,749 Est. Cost $55.61 Unrealized +28.7%
— TARO PHARMACEUTICAL INDUS 5.8%
Value ($000) $19 Shares 644,664 Est. Cost $67.97 Unrealized —
EGRX EAGLE PHARMACEUTICALS INC 1.0%
Value ($000) $3 Shares 114,825 Est. Cost $44.36 Unrealized -28.3%
KOD KODIAK SCIENCES INC 1.0%
Value ($000) $3 Shares 463,598 Est. Cost $33.04 Unrealized -78.3%
VNDA VANDA PHARMACEUTICALS INC 0.8%
Value ($000) $3 Shares 345,290 Est. Cost $10.48 Unrealized -7.1%